Correlation Between Birks and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Birks and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Birks and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Birks Group and Allovir, you can compare the effects of market volatilities on Birks and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Birks with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Birks and Allovir.

Diversification Opportunities for Birks and Allovir

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Birks and Allovir is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Birks Group and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Birks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Birks Group are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Birks i.e., Birks and Allovir go up and down completely randomly.

Pair Corralation between Birks and Allovir

Considering the 90-day investment horizon Birks Group is expected to generate 1.2 times more return on investment than Allovir. However, Birks is 1.2 times more volatile than Allovir. It trades about 0.09 of its potential returns per unit of risk. Allovir is currently generating about -0.03 per unit of risk. If you would invest  88.00  in Birks Group on August 29, 2022 and sell it today you would earn a total of  432.00  from holding Birks Group or generate 490.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Birks Group  vs.  Allovir

 Performance (%) 
       Timeline  
Birks Group 
Birks Performance
0 of 100
Over the last 90 days Birks Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Birks is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Birks Price Channel

Allovir 
Allovir Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir may actually be approaching a critical reversion point that can send shares even higher in December 2022.

Allovir Price Channel

Birks and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Birks and Allovir

The main advantage of trading using opposite Birks and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Birks position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Birks vs. Hermes Intl SA
The idea behind Birks Group and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. Regeneron Pharmaceuticals
Allovir vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go